Publication | Closed Access

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

Hematological MalignancyLymphoid NeoplasiaSingle-arm Phase 2MedicineImmunologyMyc RearrangementPathologyDose-adjusted Epoch-rAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation Oncology